William D. Waddill, a director at $PTGX, sold 4,000 shares of the company on 08-27-2025 for an estimated $237,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 30.5% of their shares of this class of stock. Following this trade, they now own 9,130 shares of this class of $PTGX stock.
$PTGX Insider Trading Activity
$PTGX insiders have traded $PTGX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $PTGX stock by insiders over the last 6 months:
- DINESH V PH D PATEL (President and CEO) has made 0 purchases and 4 sales selling 62,859 shares for an estimated $3,450,577.
- ARTURO MD MOLINA (Chief Medical Officer) has made 0 purchases and 3 sales selling 50,514 shares for an estimated $2,826,250.
- ASIF ALI (Chief Financial Officer) has made 0 purchases and 2 sales selling 26,659 shares for an estimated $1,543,329.
- WILLIAM D. WADDILL has made 0 purchases and 2 sales selling 8,000 shares for an estimated $454,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTGX Hedge Fund Activity
We have seen 169 institutional investors add shares of $PTGX stock to their portfolio, and 151 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 2,148,380 shares (+608.8%) to their portfolio in Q2 2025, for an estimated $118,740,962
- PACER ADVISORS, INC. removed 1,876,466 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $90,745,895
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 748,758 shares (+218.0%) to their portfolio in Q2 2025, for an estimated $41,383,854
- BVF INC/IL added 636,026 shares (+24.7%) to their portfolio in Q2 2025, for an estimated $35,153,157
- HOLOCENE ADVISORS, LP added 530,326 shares (+inf%) to their portfolio in Q2 2025, for an estimated $29,311,118
- DRIEHAUS CAPITAL MANAGEMENT LLC added 522,637 shares (+222.3%) to their portfolio in Q2 2025, for an estimated $28,886,146
- STATE STREET CORP added 500,924 shares (+18.5%) to their portfolio in Q2 2025, for an estimated $27,686,069
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTGX Analyst Ratings
Wall Street analysts have issued reports on $PTGX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/07/2025
- Citigroup issued a "Buy" rating on 06/17/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/03/2025
- Wedbush issued a "Outperform" rating on 03/28/2025
- Truist Securities issued a "Buy" rating on 03/11/2025
- BMO Capital issued a "Outperform" rating on 03/11/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 03/10/2025
To track analyst ratings and price targets for $PTGX, check out Quiver Quantitative's $PTGX forecast page.
$PTGX Price Targets
Multiple analysts have issued price targets for $PTGX recently. We have seen 8 analysts offer price targets for $PTGX in the last 6 months, with a median target of $71.0.
Here are some recent targets:
- Jonathan Wolleben from JMP Securities set a target price of $69.0 on 08/07/2025
- Geoff Meacham from Citigroup set a target price of $72.0 on 06/17/2025
- Douglas Tsao from HC Wainwright & Co. set a target price of $80.0 on 06/03/2025
- Yun Zhong from Wedbush set a target price of $70.0 on 03/28/2025
- Srikripa Devarakonda from Truist Securities set a target price of $76.0 on 03/11/2025
- Etzer Darout from BMO Capital set a target price of $72.0 on 03/11/2025
- Jonathan Wolleben from Citizens Capital Markets set a target price of $61.0 on 03/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
